The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

EHA 2017 | Expanding multiple myeloma advances beyond the US and Europe – an international initiative

Name: Expanding multiple myeloma advances beyond the US and Europe – an international initiative
Uploaded: 2017-06-22T00:00:00.000Z
Duration: 1 min 5 s
Description: Irene Ghobrial, MD, from the Dana-Farber Cancer Institute, Boston, MA, USA, talks about an initiative to expand multiple myeloma (MM) advances, so that we are not exclusively talking about what happens in the US or Europe, but taking a global approach to benefit more patients around the globe. Recorded at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.

Irene Ghobrial • 22 Jun 2017

EHA 2017

Multiple Myeloma

Irene Ghobrial, MD, from the Dana-Farber Cancer Institute, Boston, MA, USA, talks about an initiative to expand multiple myeloma (MM) advances, so that we are not exclusively talking about what happens in the US or Europe, but taking a global approach to benefit more patients around the globe. Recorded at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.